WuXi PharmaTech Recertified ISO 9001:2000

WuXi PharmaTech Recertified ISO 9001:2000

December 26, 2006

    SHANGHAI, China, Dec. 26 /Xinhua-PRNewswire/ -- WuXi
PharmaTech's 250,000 square foot JinShan GMP manufacturing
wholly owned subsidiary, SynTheAll Pharmaceuticals,
announced today that it has been recertified International
Organization for Standardization (ISO) 9001:2000 compliant
by SGS, a third-party auditing firm.

    (Logo:
http://www.xprn.com.cn:9080/xprn/sa/200611271812.jpg )

    Established in 2004 as the manufacturing unit of WuXi
PharmaTech, China's leading supplier of pharmaceutical
R&D outsourcing services, SynTheAll Pharmaceuticals was
initially ISO 9001:2000 certified last year.  SynTheAll
provides GMP manufacturing services including process
research, scale-up production, and Active Pharmaceutical
Intermediates (API) and advanced intermediates
manufacturing.

    "Receiving ISO 9001:2000 recertification is
testament to our unwavering commitment to quality, process
consistency, and continuous improvement.  At WuXi
PharmaTech, we are continuously raising the bar for our
quality expectations and standards.  It is wonderful to be
again recognized by ISO, however our most difficult
standard to meet, is our own," commented Dr. Ge Li,
Chairman and CEO of WuXi PharmaTech.

    SGS is the world's leading inspection, verification,
testing and certification company.  SGS is recognized as
the global benchmark for quality and integrity.  With more
than 46,000 employees, SGS operates a network of over 1,000
offices and laboratories around the world.

    ISO is a network of the national standards institutes
of 156 countries.  ISO standards specify the requirements
for state-of-the-art products, services, processes,
materials and systems, and for good conformity assessment,
managerial and organizational practice.  ISO 9001:2000 is
based on eight quality management principles: customer
focus, leadership, involvement of people, process approach,
system approach, continual improvement, fact based decision
making, and mutually beneficial supplier relationships.

    About WuXi PharmaTech 

    Founded in 2001, Shanghai-based WuXi PharmaTech is
China's leading drug R&D service company.  As a
research-driven and customer-focused company, WuXi
PharmaTech offers global pharmaceutical and
biopharmaceutical companies a diverse, value-added, and
fully integrated portfolio of outsourcing services ranging
from discovery chemistry, service biology to bioanalytical
chemistry, from process chemistry to large scale GMP
manufacturing.  WuXi PharmaTech assists its global partners
in shorting the cycle and lowering the cost of drug
discovery and development by providing cost-effective and
efficient outsourcing solutions that save our clients both
time and money.  Currently, our client list consists of 19
of the top 20 pharmaceutical, and 8 of the top 10
biopharmaceutical companies.  For more information please
visit http://www.pharmatechs.com .

    For more information, please contact:

     Sherry Shao 
     Tel:   [phone]
     Email: [e-mail]


SOURCE  WuXi PharmaTech Co., Ltd.